Please login to the form below

Not currently logged in
Email:
Password:

Precision Medicine Group acquires Ethos

The services company will boost PMG's capabilities in complex data interpretation

Precision Medicine GroupPrecision Medicine Group has added another string to its bow not long after its healthcare advertising arm precisioneffect bought marketing healthcare agency Big Pink.

This time, the company has acquired ETHOS Health Communications, a Pennsylvania, US-based agency specialising in the interpretation and communication of medical science.

ETHOS has been operating for 15 years and has a history of working with biopharmaceutical and biotechnology firms, offering physicians, providers and other stakeholders medical affairs and marketing-based scientific knowledge.

Precision Medicine Group’s new asset will provide its clients with an expanded cadre of science and medical communications specialists.

Commenting on the acquisition, Precision Medicine Group’s CEO, Mark Clein said: “As medical innovations become increasingly complex, the demand for clarity, insight and compelling communications becomes a fundamental success factor for drug developers seeking to convey the medical and economic benefits of their products.

“With ETHOS, these developers can better translate their science to the multiple constituents that prescribe, utilise, regulate and insure their products.

“With this addition, Precision has enhanced our proficiency in demonstrating the clinical value of medical innovations throughout the entire development and commercial life cycle.”

ETHOS, home to over 120 employees, is led by co-founder and president Anita O’Connor, who will join the leadership team at Precision Value & Health.

She said: “We are very happy to be joining the Precision family and partnering with other Precision teams to provide the highest level of expertise to help our clients achieve their objectives and to bring the best science and medicine to patients and healthcare professionals.

“Our company culture and mission align very closely with Precision’s, and we are very excited about the added value we can now offer both existing and new clients.”

Article by
Gemma Jones

18th July 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...